MGX
Metagenomi (MGX)
$73
About Metagenomi (MGX)
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Details
Daily high
$1.78
Daily low
$1.72
Price at open
$1.75
52 Week High
$4.00
52 Week Low
$1.23
Market cap
65.7M
Dividend yield
0.00%
Volume
94,053
Avg. volume
331,358
P/E ratio
-.73
Metagenomi News
Details
Daily high
$1.78
Daily low
$1.72
Price at open
$1.75
52 Week High
$4.00
52 Week Low
$1.23
Market cap
65.7M
Dividend yield
0.00%
Volume
94,053
Avg. volume
331,358
P/E ratio
-.73